|
| 37971861 | Increased intraindividual variability in reaction time performance is associated with emerging cognitive decline in cognitively unimpaired adults. | Neuropsychology | 2024 |
| 37991080 | Early Detection of Amyloid-Related Changes in Memory among Cognitively Unimpaired Older Adults with Daily Digital Testing. | Ann Neurol | 2024 |
| 37830926 | Eligibility Rates among Racially and Ethnically Diverse US Participants in Phase 2 and Phase 3 Placebo-Controlled, Double-Blind, Randomized Trials of Lecanemab and Elenbecestat in Early Alzheimer Disease. | Ann Neurol | 2024 |
| 37932961 | Plasma Aβ42/Aβ40 and phospho-tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's disease. | Alzheimers Dement | 2024 |
| 38038976 | Relationships of Cognitive Measures with Cerebrospinal Fluid but Not Imaging Biomarkers of Alzheimer Disease Vary between Black and White Individuals. | Ann Neurol | 2024 |
| 37728659 | Contribution of extracerebral tracer retention and partial volume effects to sex differences in Flortaucipir-PET signal. | J Cereb Blood Flow Metab | 2024 |
| 37971862 | Capturing learning curves with the multiday Boston Remote Assessment of Neurocognitive Health (BRANCH): Feasibility, reliability, and validity. | Neuropsychology | 2024 |
| 35298083 | Waning locus coeruleus integrity precedes cortical tau accrual in preclinical autosomal dominant Alzheimer's disease. | Alzheimers Dement | 2023 |
| 37968130 | Association of Pathologic and Volumetric Biomarker Changes With Cognitive Decline in Clinically Normal Adults. | Neurology | 2023 |
| 37528163 | Cortical microstructural changes predict tau accumulation and episodic memory decline in older adults harboring amyloid. | Commun Med (Lond) | 2023 |
| 37491329 | Association of Novelty-Related Locus Coeruleus Function With Entorhinal Tau Deposition and Memory Decline in Preclinical Alzheimer Disease. | Neurology | 2023 |
| 38012286 | Tangles, not TANGO: targeting tau aggregates. | Nat Aging | 2023 |
| 37899618 | Editorial: Are We There Yet (and How Do We Get There⿦)? | J Prev Alzheimers Dis | 2023 |
| 37848035 | Accelerating Alzheimer's therapeutic development: The past and future of clinical trials. | Cell | 2023 |
| 37843849 | Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease. | JAMA Neurol | 2023 |
| 38036535 | Cell-type-specific Alzheimer's disease polygenic risk scores are associated with distinct disease processes in Alzheimer's disease. | Nat Commun | 2023 |
| 35862098 | Harmonizing the preclinical Alzheimer cognitive composite for multicohort studies. | Neuropsychology | 2023 |
| 37458272 | Trial of Solanezumab in Preclinical Alzheimer's Disease. | N Engl J Med | 2023 |
| 37291760 | Location of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal-dominant Alzheimer's disease. | Aging Cell | 2023 |
| 36993271 | Novel <i>CYP1B1-RMDN2</i> Alzheimer's disease locus identified by genome-wide association analysis of cerebral tau deposition on PET. | medRxiv | 2023 |
| 36950699 | Computerized cognitive practice effects in relation to amyloid and tau in preclinical Alzheimer's disease: Results from a multi-site cohort. | Alzheimers Dement (Amst) | 2023 |
| 37218387 | Subjective cognitive decline across ethnoracial groups in the A4 study. | Alzheimers Dement | 2023 |
| 37188781 | Resilience to autosomal dominant Alzheimer's disease in a Reelin-COLBOS heterozygous man. | Nat Med | 2023 |
| 37020050 | Ultra-high field imaging, plasma markers and autopsy data uncover a specific rostral locus coeruleus vulnerability to hyperphosphorylated tau. | Mol Psychiatry | 2023 |
| 37212093 | Associations of the Harvard Automated Phone Task and Alzheimer's Disease Pathology in Cognitively Normal Older Adults: Preliminary Findings. | J Alzheimers Dis | 2023 |
| 37182868 | Association of Alcohol Consumption with Cognition in Older Population: The A4 Study. | J Alzheimers Dis | 2023 |
| 37010830 | Association of Age at Menopause and Hormone Therapy Use With Tau and β-Amyloid Positron Emission Tomography. | JAMA Neurol | 2023 |
| 37276136 | Linking self-perceived cognitive functioning questionnaires using item response theory: The subjective cognitive decline initiative. | Neuropsychology | 2023 |
| 37304049 | Relation of modifiable lifestyle and mood factors to cognitive concerns among participants and their study partners in the A4 screen data. | Alzheimers Dement (Amst) | 2023 |
| 37333223 | Cell-type-specific Alzheimer's disease polygenic risk scores are associated with distinct disease processes in Alzheimer's disease. | medRxiv | 2023 |
| 36710683 | Evaluation of Blood-Based Plasma Biomarkers as Potential Markers of Amyloid Burden in Preclinical Alzheimer's Disease. | J Alzheimers Dis | 2023 |
| 36571821 | Plasma p-tau217 predicts in vivo brain pathology and cognition in autosomal dominant Alzheimer's disease. | Alzheimers Dement | 2023 |
| 36597122 | APOE effects on regional tau in preclinical Alzheimer's disease. | Mol Neurodegener | 2023 |
| 35971310 | The AHEAD 3-45 Study: Design of a prevention trial for Alzheimer's disease. | Alzheimers Dement | 2023 |
| 35962782 | Tau positron emission tomography in preclinical Alzheimer's disease. | Brain | 2023 |
| 34160128 | Plasma IL-12/IFN-γ axis predicts cognitive trajectories in cognitively unimpaired older adults. | Alzheimers Dement | 2022 |
| 35841244 | Subjective Cognitive Decline in a Registry Sample: Relation to Psychiatric History, Loneliness, and Personality. | J Prev Alzheimers Dis | 2022 |
| 35380901 | Amyloid-β and tau pathologies relate to distinctive brain dysconnectomics in preclinical autosomal-dominant Alzheimer's disease. | Proc Natl Acad Sci U S A | 2022 |
| 35440022 | Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer's disease. | Alzheimers Res Ther | 2022 |
| 35838824 | Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer's dementia. | Acta Neuropathol | 2022 |
| 35473760 | Association of β-Amyloid and Vascular Risk on Longitudinal Patterns of Brain Atrophy. | Neurology | 2022 |
| 35471588 | Menopause Status Moderates Sex Differences in Tau Burden: A Framingham PET Study. | Ann Neurol | 2022 |
| 35470142 | Predicting Amyloid Positivity in Cognitively Unimpaired Older Adults: A Machine Learning Approach Using A4 Data. | Neurology | 2022 |
| 35435938 | Divergent Cortical Tau Positron Emission Tomography Patterns Among Patients With Preclinical Alzheimer Disease. | JAMA Neurol | 2022 |
| 35670654 | Progressive White Matter Injury in Preclinical Dutch Cerebral Amyloid Angiopathy. | Ann Neurol | 2022 |
| 35821672 | Physical activity is associated with increased resting-state functional connectivity in networks predictive of cognitive decline in clinically unimpaired older adults. | Alzheimers Dement (Amst) | 2022 |
| 35552371 | Sex differences in the genetic architecture of cognitive resilience to Alzheimer's disease. | Brain | 2022 |
| 35908251 | The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease. | Alzheimers Dement | 2022 |
| 35907254 | Association of Elevated Amyloid and Tau Positron Emission Tomography Signal With Near-Term Development of Alzheimer Disease Symptoms in Older Adults Without Cognitive Impairment. | JAMA Neurol | 2022 |
| 35871328 | Association of Carotid Intima Media Thickening with Future Brain Region Specific Amyloid-β Burden. | J Alzheimers Dis | 2022 |